Published in J Clin Oncol on November 23, 2009
Planning Advance Care Together (PACT) to Improve Engagement in Advance Care Planning | NCT04515810
Bending the cost curve in cancer care. N Engl J Med (2011) 5.02
Patient-physician communication about code status preferences: a randomized controlled trial. Cancer (2013) 1.66
A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer. J Support Oncol (2011) 1.38
Advance directives in an oncologic intensive care unit: a contemporary analysis of their frequency, type, and impact. J Palliat Med (2011) 1.09
Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol (2015) 1.04
Dancing around death: hospitalist-patient communication about serious illness. Qual Health Res (2012) 0.90
The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directives. Support Care Cancer (2012) 0.87
Advance directives: prevalence and attitudes of cancer patients receiving radiotherapy. Support Care Cancer (2012) 0.86
Building on Individual, State, and Federal Initiatives for Advance Care Planning, an Integral Component of Palliative and End-of-Life Cancer Care. J Oncol Pract (2011) 0.84
Understanding how cancer patients actualise, relinquish, and reject advance care planning: implications for practice. Support Care Cancer (2013) 0.83
Communication and palliative care in a 64-year-old man with pancreatic adenocarcinoma. Gastrointest Cancer Res (2012) 0.78
Old age and poor prognosis increase the likelihood of disagreement between cancer patients and their oncologists on the indication for resuscitation attempt. Support Care Cancer (2013) 0.77
Advance care planning among hematopoietic cell transplant patients and bereaved caregivers. Bone Marrow Transplant (2014) 0.76
Knowledge, attitudes, and influencing factors of cancer patients toward approving advance directives in China. Support Care Cancer (2016) 0.75
Opportunities to maximize value with integrated palliative care. J Multidiscip Healthc (2016) 0.75
Advance care planning as a shared endeavor: completion of ACP documents in a multidisciplinary cancer program. Psychooncology (2015) 0.75
Advance care planning knowledge and documentation in a hospitalized cancer population. Proc (Bayl Univ Med Cent) (2013) 0.75
A mixed method feasibility study of a patient- and family-centred advance care planning intervention for cancer patients. BMC Palliat Care (2015) 0.75
Is there a right not to know? Nat Rev Clin Oncol (2017) 0.75
Seriously ill hospitalized patients' perspectives on the benefits and harms of two models of hospital CPR discussions. Patient Educ Couns (2013) 0.75
Guiding patients facing decisions about "futile" chemotherapy. J Support Oncol (2011) 0.75
Palliative oncology: identity, progress, and the path ahead. Ann Oncol (2012) 0.75
Using a Non-Fit Message Helps to De-Intensify Negative Reactions to Tough Advice. Pers Soc Psychol Bull (2016) 0.75
Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA (2008) 11.32
Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ (2000) 8.44
Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med (2000) 7.20
Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46
The inner life of physicians and care of the seriously ill. JAMA (2001) 4.86
Opening the black box: how do physicians communicate about advance directives? Ann Intern Med (1998) 3.98
The role of chemotherapy at the end of life: "when is enough, enough?". JAMA (2008) 3.31
Differences in end-of-life decision making among black and white ambulatory cancer patients. J Gen Intern Med (1996) 2.67
The status of medical education in end-of-life care: a national report. J Gen Intern Med (2003) 2.50
Racial and ethnic differences in advance care planning among patients with cancer: impact of terminal illness acknowledgment, religiousness, and treatment preferences. J Clin Oncol (2008) 2.30
How do medical residents discuss resuscitation with patients? J Gen Intern Med (1995) 2.20
Paradoxes in cancer patients' advance care planning. J Palliat Med (2000) 2.11
Communication between physicians and family caregivers about care at the end of life: when do discussions occur and what is said? J Palliat Med (2005) 2.05
Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol (2004) 1.88
The discussion about advance directives. Patient and physician opinions regarding when and how it should be conducted. End of Life Study Group. Arch Intern Med (1995) 1.77
Dying with cancer: patients' function, symptoms, and care preferences as death approaches. J Am Geriatr Soc (2000) 1.58
A qualitative study of oncologists' approaches to end-of-life care. J Palliat Med (2008) 1.49
"I'm sorry to tell you ..." physicians' reports of breaking bad news. J Behav Med (2001) 1.32
Diagnosing and discussing imminent death in the hospital: a secondary analysis of physician interviews. J Palliat Med (2007) 1.31
Advance directives: time to move on. Ann Intern Med (2004) 1.24
Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning. J Clin Oncol (2007) 1.02
Medical residents' perceptions of end-of-life care training in a large urban teaching hospital. J Palliat Med (2003) 1.02
Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients: prevalence and identification of research focus. J Pain Symptom Manage (2003) 0.97
Communicating with patients and their families about advance care planning and end-of-life care. Respir Care (2000) 0.93
Lack of concordance between physician and patient: reports on end-of-life care discussions. J Palliat Med (2007) 0.88
How long does it take to get a "do not resuscitate" order? J Palliat Care (1997) 0.87
Structure of the 30S ribosomal subunit. Nature (2000) 23.11
The genome sequence of the malaria mosquito Anopheles gambiae. Science (2002) 20.36
Structure of the 70S ribosome complexed with mRNA and tRNA. Science (2006) 12.25
Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics. Nature (2000) 11.30
A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. Science (2002) 9.59
Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science (2001) 8.68
Cost of care for elderly cancer patients in the United States. J Natl Cancer Inst (2008) 7.85
American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol (2012) 7.16
American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol (2009) 6.77
American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003. J Clin Oncol (2003) 6.66
Selection of tRNA by the ribosome requires a transition from an open to a closed form. Cell (2002) 5.62
Identification of the platelet ADP receptor targeted by antithrombotic drugs. Nature (2001) 5.51
Structural insights into translational fidelity. Annu Rev Biochem (2005) 4.97
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer. J Clin Oncol (2009) 4.95
Tumor boards and the quality of cancer care. J Natl Cancer Inst (2012) 4.87
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med (2004) 4.84
The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell (2000) 4.82
American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol (2011) 4.64
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol (2006) 4.61
Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst (2008) 4.53
The structure of the ribosome with elongation factor G trapped in the posttranslocational state. Science (2009) 4.26
Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm. J Biol Chem (2009) 4.05
What recent ribosome structures have revealed about the mechanism of translation. Nature (2009) 4.01
Sexual orientation and suicidality: a co-twin control study in adult men. Arch Gen Psychiatry (1999) 3.97
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol (2007) 3.91
Crystal structure of the 30 S ribosomal subunit from Thermus thermophilus: structure of the proteins and their interactions with 16 S RNA. J Mol Biol (2002) 3.76
Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol (2006) 3.71
A detailed view of a ribosomal active site: the structure of the L11-RNA complex. Cell (1999) 3.70
Early specialty palliative care--translating data in oncology into practice. N Engl J Med (2013) 3.58
Crystal structure of an initiation factor bound to the 30S ribosomal subunit. Science (2001) 3.51
The eukaryotic translation initiation factors eIF1 and eIF1A induce an open conformation of the 40S ribosome. Mol Cell (2007) 3.44
The role of chemotherapy at the end of life: "when is enough, enough?". JAMA (2008) 3.31
Insights into substrate stabilization from snapshots of the peptidyl transferase center of the intact 70S ribosome. Nat Struct Mol Biol (2009) 3.25
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. J Clin Oncol (2011) 3.21
Structure of a bacterial 30S ribosomal subunit at 5.5 A resolution. Nature (1999) 3.12
Starch catabolism by a prominent human gut symbiont is directed by the recognition of amylose helices. Structure (2008) 3.02
Patient time costs associated with cancer care. J Natl Cancer Inst (2007) 2.90
The shortage of essential chemotherapy drugs in the United States. N Engl J Med (2011) 2.74
Palliative care and oncology partnerships in real practice. Oncology (Williston Park) (2011) 2.72
Insights into the decoding mechanism from recent ribosome structures. Trends Biochem Sci (2003) 2.71
GTPase activation of elongation factor EF-Tu by the ribosome during decoding. EMBO J (2009) 2.71
Visualizing tmRNA entry into a stalled ribosome. Science (2003) 2.67
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2012) 2.62
Crystal structures of the ribosome in complex with release factors RF1 and RF2 bound to a cognate stop codon. Cell (2005) 2.46
A complete mapping of the proteins in the small ribosomal subunit of Escherichia coli. Science (1987) 2.43
Talking with patients about dying. N Engl J Med (2012) 2.34
Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Ann Intern Med (2011) 2.34
Hospital mortality rates: how is palliative care taken into account? J Pain Symptom Manage (2010) 2.32
Prevalence of asthma and other allergic diseases in an adolescent population: association with gender and race. Ann Allergy Asthma Immunol (2001) 2.19
Elongation factor G bound to the ribosome in an intermediate state of translocation. Science (2013) 2.12
Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol (2002) 2.12
Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med (2003) 2.11
How mutations in tRNA distant from the anticodon affect the fidelity of decoding. Nat Struct Mol Biol (2011) 2.10
Lung cancer in railroad workers exposed to diesel exhaust. Environ Health Perspect (2004) 2.06
The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells. Comparison with the thrombin receptor. J Biol Chem (1996) 2.05
Calcite precipitation induced by polyurethane-immobilized Bacillus pasteurii. Enzyme Microb Technol (2001) 2.04
Providing pain and palliative care education internationally. J Support Oncol (2011) 2.04
Lung cancer and elemental carbon exposure in trucking industry workers. Environ Health Perspect (2012) 2.04
Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing. J Clin Oncol (2009) 2.03
End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector. Cancer (2010) 2.01
Relationships of race and socioeconomic status with prevalence, severity, and symptoms of asthma in Chicago school children. Ann Allergy Asthma Immunol (1998) 2.01
The structural basis for mRNA recognition and cleavage by the ribosome-dependent endonuclease RelE. Cell (2009) 2.01
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol (2012) 2.00
Structure of the histone acetyltransferase Hat1: a paradigm for the GCN5-related N-acetyltransferase superfamily. Cell (1998) 1.96
Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control (2003) 1.86
Is it time for (survivorship care) plan B? J Clin Oncol (2011) 1.84
Residential exposure to petrochemicals and the risk of leukemia: using geographic information system tools to estimate individual-level residential exposure. Am J Epidemiol (2006) 1.84
Chromatin higher-order structure studied by neutron scattering and scanning transmission electron microscopy. Proc Natl Acad Sci U S A (1987) 1.77
Advances in microbicide vaginal rings. Antiviral Res (2010) 1.76
SPIKE$: a six-step protocol for delivering bad news about the cost of medical care. J Clin Oncol (2008) 1.76
Quantifying the predictability of diaphragm motion during respiration with a noninvasive external marker. Med Phys (2003) 1.76
Linker histone-dependent DNA structure in linear mononucleosomes. J Mol Biol (1996) 1.76
Crystal structure of the 30 S ribosomal subunit from Thermus thermophilus: purification, crystallization and structure determination. J Mol Biol (2001) 1.74
Spatial modeling of PM10 and NO2 in the continental United States, 1985-2000. Environ Health Perspect (2009) 1.73
Fatal Loeffler's endocarditis due to hypereosinophilic syndrome. Am J Hematol (2007) 1.73
The association of particulate air metal concentrations with heart rate variability. Environ Health Perspect (2002) 1.71
Crystal structure of the histone acetyltransferase Hpa2: A tetrameric member of the Gcn5-related N-acetyltransferase superfamily. J Mol Biol (1999) 1.70
Area-level variations in cancer care and outcomes. Med Care (2012) 1.68
Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. J Biol Chem (2010) 1.68
Structure of a purine-purine wobble base pair in the decoding center of the ribosome. Nat Struct Mol Biol (2004) 1.66
Structural basis of the translational elongation cycle. Annu Rev Biochem (2013) 1.65
Green tea polyphenols modulate insulin secretion by inhibiting glutamate dehydrogenase. J Biol Chem (2006) 1.64
Understanding variation in primary prostate cancer treatment within the Veterans Health Administration. Urology (2012) 1.62
Position and orientation of the globular domain of linker histone H5 on the nucleosome. Nature (1998) 1.62
Reasons why physicians do not have discussions about poor prognosis, why it matters, and what can be improved. J Clin Oncol (2012) 1.60
Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors. Transplantation (2004) 1.59
Mechanism for expanding the decoding capacity of transfer RNAs by modification of uridines. Nat Struct Mol Biol (2007) 1.58
Identification of two DNA-binding sites on the globular domain of histone H5. EMBO J (1996) 1.57
Lung cancer and vehicle exhaust in trucking industry workers. Environ Health Perspect (2008) 1.57
Solvatochromic study of 1,2-dihydroxyanthraquinone in neat and binary solvent mixtures. Spectrochim Acta A Mol Biomol Spectrosc (2007) 1.55
Crystal structure of prokaryotic ribosomal protein L9: a bi-lobed RNA-binding protein. EMBO J (1994) 1.52
Does oral antiandrogen use before leuteinizing hormone-releasing hormone therapy in patients with metastatic prostate cancer prevent clinical consequences of a testosterone flare? Urology (2009) 1.52
Location of translational initiation factor IF3 on the small ribosomal subunit. Proc Natl Acad Sci U S A (1999) 1.51
Structural evidence for specific S8-RNA and S8-protein interactions within the 30S ribosomal subunit: ribosomal protein S8 from Bacillus stearothermophilus at 1.9 A resolution. Structure (1996) 1.49
Improving the quality of cancer care: implications for palliative care. J Palliat Med (2014) 1.49
Structure of antibody-neutralized murine norovirus and unexpected differences from viruslike particles. J Virol (2007) 1.49
Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol (2006) 1.48
Crystal structure of the ribosome recycling factor bound to the ribosome. Nat Struct Mol Biol (2007) 1.45
American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer. J Clin Oncol (2004) 1.44
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282. Int J Radiat Oncol Biol Phys (2005) 1.43